| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.7M | +354.7% |
| R&D Expense | $73.1M | -3.3% |
| SG&A Expense | $22.9M | +24.7% |
| Operating Income | -$90.3M | +2.7% |
| Income Tax | $0 | — |
| Net Income | -$88.1M | +10.6% |
| EPS (Basic) | -$2.36 | +20.5% |
| EPS (Diluted) | -$2.36 | +20.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.2M | -66.2% |
| Short-term Investments | $159.6M | +0.5% |
| Current Assets | $172.7M | -8.7% |
| Total Assets | $227.8M | -26.0% |
| Current Liabilities | $23.1M | +8.4% |
| Total Liabilities | $56.3M | -2.3% |
| Stockholders' Equity | $171.5M | -31.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$76.5M | -34.1% |
| Capital Expenditures | $2.0M | -16.5% |
| Investing Cash Flow | $57.9M | +124.9% |
| Financing Cash Flow | $503K | -99.8% |
| Free Cash Flow | -$78.5M | -32.1% |